JenaValve is developing a minimally invasive, self-expanding aortic heart valve implantation and delivery system that offers a flexible conduit, exact positioning and secure implantation to provide patients with a life-sustaining heart valve replacement. The company's product, JenaValve™, is initially aimed at high-risk patients unsuitable for open heart surgery. As the system becomes the AVR procedure of choice, it is expected that its benefits will become equally attractive to all other potential patients.
In the News:
